, , , e.a.

Cardiovascular PET: Current Concepts

Gebonden Engels 2019 9781259860485
€ 140,39
Levertijd ongeveer 11 werkdagen
Gratis verzonden

Samenvatting

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.

An expertly written state-of-the-art review of every aspect of cardiovascular PET imaging

Filling a void in the medical literature, this much needed resource clearly and succinctly reviews the current knowledge and practical aspects of cardiovascular PET. With coverage that spans everything from instrumentation to clinical procedures to the future directions of cardiac PET, the intent and focus of this book is to provide readers with the most current, reliable, and clinically relevant data in one concise, focused resource.  

Essential for anyone preparing for the board exam in nuclear medicine, Cardiovascular PET: Current Concepts is organized into six sections:

• Current Concepts of Cardiovascular PET Imaging: The New Paradigm

• Clinical Overview of Contemporary Myocardial Perfusion Imaging with Cardiac PET

• Quantitative Myocardial Blood Flow Assessment

• Technical Developments in Cardiovascular PET

• Myocardial Viability Assessment: The Current Rule of Cardiac PET

• Current Status of Assessment of Cardiovascular Inflammation and Infection Imaging

Each chapter concludes with an informative “Editor’s Perspective” in which one of the editors places the material discussed in the chapter into real-world clinical perspective. 

If you would like a better understanding of cardiovascular PET, or want to incorporate it into your own clinical practice, this book is required reading.

Specificaties

ISBN13:9781259860485
Taal:Engels
Bindwijze:gebonden

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

<p><B><span>Section I: Technical Developments in Cardiovascular PET </SPAN></B></P><p><span><SPAN>1.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>Cardiovascular PET Cameras: detectors: BSO vs. LSO/LYSO, line source vs. hybrid PET/CT, 3-D versus 2D acquisition, etc </SPAN></P><p><span><SPAN>2.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>Cyclotrons, Generators, Delivery systems for Cardiac PET imaging </SPAN></P><p><span><SPAN>3.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>Radiation Exposure with Cardiovascular PET: new data </SPAN></P><p><span><SPAN>4.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>&nbsp;</SPAN></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B>Section II: New Developments in Myocardial Perfusion Imaging with Cardiac PET </B></SPAN></P><p><B><span>&nbsp;</SPAN></B></P><p><span><SPAN>5.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>Clinical Update: Indications, Protocols, Accuracy, Risk stratification </SPAN></P><p><span><SPAN>6.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>Hybrid Imaging: Value of Calcium Scoring with case examples </SPAN></P><p><span><SPAN>7.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>Quantitative myocardial blood flow – technical and quality control issues with case examples </SPAN></P><p><span><SPAN>8.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>Quantitative myocardial blood flow – clinical importance with case examples </SPAN></P><p><span><SPAN>9.<span>&nbsp;&nbsp;&nbsp; </SPAN></SPAN></SPAN><span>&nbsp;</SPAN></P><p><B><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Section III: New Developments in Viability Assessment with Cardiac PET</SPAN></B></P><p><B><span>&nbsp;</SPAN></B></P><p><span><SPAN>10.<span> </SPAN></SPAN></SPAN><span>Clinical update on role and value </SPAN></P><p><span>Patient preparation for FDG viability: diabetic and non-diabetic</SPAN></P><p><span>Interpretation of PET viability studies with examples</SPAN></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></P><p><B><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Section IV:&nbsp; Current Status of Assessment of&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cardiac Sarcoid with FDG Imaging </SPAN></B></P><p><B><span>&nbsp;</SPAN></B></P><p><span><SPAN>11.<span> </SPAN></SPAN></SPAN><span>Clinical need: current assessment</SPAN></P><p><span>Patient preparation</SPAN></P><p><span>Supportive data&nbsp; </SPAN></P><p><span>How to do: value of MRI?</SPAN></P><p><span>Interpretation of cardiac sarcoid studies with case examples</SPAN></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp; Assessment of therapies: timing, indications</SPAN></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting cardiac sarcoid studies&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></P><p><span>&nbsp;</SPAN></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B>Section V: Infection and Vascular Inflammation&nbsp; </B></SPAN></P><p><span><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Imaging </B></SPAN></P><p><B><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></B></P><p><B><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></B><span>10. Infection imaging: ICD, leads, endocarditis </SPAN></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;</SPAN></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B>Section VI: New Tracers in Cardiovascular PET </B></SPAN></P><p><B><span>&nbsp;</SPAN></B></P><p><B><span>&nbsp;</SPAN></B></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11. Flurpiridaz to be the primary topic </SPAN></P><p><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </SPAN></P>

Managementboek Top 100

€ 140,39
Levertijd ongeveer 11 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Cardiovascular PET: Current Concepts